Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pathogenic Escherichia coli in inflammatory bowel diseases

Published byStanley Conley Modified over 6 years ago

Similar presentations

Presentation on theme: "Pathogenic Escherichia coli in inflammatory bowel diseases"— Presentation transcript:

1 Pathogenic Escherichia coli in inflammatory bowel diseases
Arlette Darfeuille-Michaud, Jean-Frédéric Colombel  Journal of Crohn's and Colitis  Volume 2, Issue 3, Pages (September 2008) DOI: /j.crohns Copyright © 2008 European Crohn's and Colitis Organisation. Terms and Conditions

2 Figure 1 Colonization of the ileal mucosa by AIEC bacteria. Adherent-invasive E. coli adhere via type 1 pili to CEACAM6, that is the abnormally expressed by intestinal epithelial cells in CD patients. The invasive phenotype of AIEC allow the bacteria to cross the mucosal barrier. AIEC bacteria can survive and replicate within infected macrophages underlining the epithelial barrier and induce TNF-α secretion. Journal of Crohn's and Colitis 2008 2, DOI: ( /j.crohns ) Copyright © 2008 European Crohn's and Colitis Organisation. Terms and Conditions

3 Figure 2 Proposed model for the association between E. coli and the pathogenesis of UC. Journal of Crohn's and Colitis 2008 2, DOI: ( /j.crohns ) Copyright © 2008 European Crohn's and Colitis Organisation. Terms and Conditions

4 Figure 3 The bowel mucosa of a CD patient mounts a defective early acute immune response to invading bacteria, as compared to the normal bowel mucosa. This defective response allows bacterial influx, which leads to chronic inflammation in the gut. Journal of Crohn's and Colitis 2008 2, DOI: ( /j.crohns ) Copyright © 2008 European Crohn's and Colitis Organisation. Terms and Conditions

5 Figure 4 Prevalence (proportion of individuals from which AIEC were isolated) and relative abundance (proportion of AIEC among the number of E. coli isolates analyzed) of AIEC isolated from biopsy samples of colonic mucosa. CD, CD patients (N=15); C, healthy controls (N=13). Journal of Crohn's and Colitis 2008 2, DOI: ( /j.crohns ) Copyright © 2008 European Crohn's and Colitis Organisation. Terms and Conditions

6 Figure 5 Scanning electron micrographs of a PBMC aggregate induced by E. coli strain LF82 (Day 9 of incubation). Macrophages appear to be the predominant cell type, although lymphocytes are also present (arrow, left). The numerous villosities seen on the macrophages (right panel) suggest that these cells are intensely active. Bars represent 5 µm; degrees of magnification are as indicated. Journal of Crohn's and Colitis 2008 2, DOI: ( /j.crohns ) Copyright © 2008 European Crohn's and Colitis Organisation. Terms and Conditions

Download ppt "Pathogenic Escherichia coli in inflammatory bowel diseases"

Similar presentations

Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.

Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Volume 130, Issue 2, Pages (February 2006)

Volume 130, Issue 2, Pages (February 2006)
Work disability in inflammatory bowel disease

Work disability in inflammatory bowel disease
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.
Disseminated Cryptococcus neoformans infection and Crohn's disease in an immunocompetent patient  Guido Sciaudone, Gianluca Pellino, Ilaria Guadagni,

Disseminated Cryptococcus neoformans infection and Crohn's disease in an immunocompetent patient  Guido Sciaudone, Gianluca Pellino, Ilaria Guadagni,
How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,
Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.

Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.
Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn’s Disease–Like Ileitis: What is the Right Model?  Fabio Cominelli,

Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn’s Disease–Like Ileitis: What is the Right Model?  Fabio Cominelli,
Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
YouTube® and inflammatory bowel disease

YouTube® and inflammatory bowel disease
Leigh A. Beamish, Alvaro R. Osornio-Vargas, Eytan Wine 

Leigh A. Beamish, Alvaro R. Osornio-Vargas, Eytan Wine 
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Association of a Nkx2-3 polymorphism with Crohn's disease and expression of Nkx2-3 is up-regulated in B cell lines and intestinal tissues with Crohn's.

Association of a Nkx2-3 polymorphism with Crohn's disease and expression of Nkx2-3 is up-regulated in B cell lines and intestinal tissues with Crohn's.
Expression and functional analysis of intestinal organic cation/l-carnitine transporter (OCTN) in Crohn's Disease  Marc Girardin, Serge Dionne, Philippe.

Expression and functional analysis of intestinal organic cation/l-carnitine transporter (OCTN) in Crohn's Disease  Marc Girardin, Serge Dionne, Philippe.
Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells  Ashok Kumar.

Microscopic colitis patients have increased proportions of Ki67+ proliferating and CD45RO+ active/memory CD8+ and CD4+8+ mucosal T cells  Ashok Kumar.

Similar presentations

Ads by Google